Site icon OncologyTube

Goals for precision medicine in NSCLC

Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses precision medicine at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland. She explains how precision medicine relies upon molecular testing, biomarkers, and drug availability, and that the key issue to tackle is making drugs more widely available for the purposes of precision medicine across Europe.

Exit mobile version